Lila Sciences
Checked
A company building automated labs guided by AI.
- Location
- Cambridge · SF · London
- Funding
- $2B · Series B · database recordReported ·
- Valuation
- $8.5B · basis differs
What the figures mean
Forge’s record, reviewed October 9, 2026, lists July 31 B-1 and B-2 entries of $1.46B and $540M: $2B combined. Forge labels $8.5B post-money. Bloomberg’s June 3 report described financing talks at $8.5B before new money. The dates and valuation bases differ; this is a database-reported financing, not a company-confirmed reconciliation. Separately, Lila announced a $350M Series A in 2025, bringing total funding then to $550M.
Locations listed on the company contact page; this does not designate a sole headquarters. Reviewed October 9, 2026.
Founding team
Co-founders include Geoffrey von MaltzahnMolly Gibson
Selected co-founders, identified by company and institutional biographies; not the complete founding group.
Sources
- Forge — July financing record ↗
Two Series B share classes and database-reported valuation.
- Bloomberg — June financing talks ↗
Earlier reporting uses a pre-money basis; negotiations are not a closed round.
- Lila — company-confirmed Series A ↗
$350M Series A, bringing total funding to $550M; do not confuse the round with total capital.
- Lila — Geoffrey von Maltzahn ↗
Founder biography.
- Harvard Medical School — Molly Gibson ↗
Co-founder biography.
A dated snapshot of the public sources reviewed, not a live funding feed. Figures marked “reported” have not been independently confirmed with the company.